Directors dealings

Director dealings: Trufin CEO snaps up more shares
25 Sep, 2026 12:38
(Sharecast News) - Trufin revealed on Friday that chief executive James van den Bergh had acquired 25,000 ordinary shares in the AIM-listed software firm.
Director dealings: Oxford Biomedica chair ups stake
24 Sep, 2026 09:19
(Sharecast News) - The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.
Director dealings: Intercede's Dan O'Brien raises stake
23 Sep, 2026 14:23
(Sharecast News) - Intercede Group revealed on Wednesday that non-executive director Dan O'Brien had acquired 22,070 ordinary shares in the AIM-listed cybersecurity software firm.
Director dealings: Foreterra non-executive director snaps up shares
22 Sep, 2026 13:29
(Sharecast News) - Forterra revealed on Tuesday that non-executive director Gavin Hill had acquired 28,944 ordinary shares in the London-listed building products manufacturer.
Director dealings: Trufin CEO raises stake
21 Sep, 2026 12:05
(Sharecast News) - Trufin revealed on Monday that chief executive James van den Bergh had acquired 150,000 ordinary shares in the AIM-listed software firm.
Director dealings: Astrazeneca CEO raises stake
18 Sep, 2026 14:14
(Sharecast News) - Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker.
Director dealings: McBride CFO lowers stake
17 Sep, 2026 12:11
(Sharecast News) - McBride said on Thursday that chief financial officer Marck Strickland had disposed of 110,000 ordinary shares in the London-listed household goods manufacturer.
Director dealings: Hilton Food CEO snaps up shares
16 Sep, 2026 14:56
(Sharecast News) - Hilton Food Group revealed on Wednesday that chief executive Mark Allen had acquired 14,500 ordinary shares in the FTSE 250-listed food packaging business.
Director dealings: Kromek chairman raises stake
15 Sep, 2026 12:53
(Sharecast News) - Kromek Group revealed on Tuesday that chairman Rakesh Sharma had acquired 145,454 ordinary shares in the AIM-listed global detection firm.
Director dealings: Fevertree chairman raises stake
14 Sep, 2026 12:22
(Sharecast News) - Fevertree Drinks revealed on Monday that chairman Domenic De Lorenzo had acquired 44,674 ordinary shares in the AIM-listed non-alcholic drinksmaker.

Existing client?
Log in to your account »

Important information

Spread Betting and CFD trading carry a high level of risk to your capital; you should ensure you understand the risks involved. Please read the full risk warning.

Have a question?

Call us on 0117 988 9915
8.00am to 6.00pm (Monday to Friday)

HL Markets account holders
Call us on 020 7573 0055
Email us

ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Spread Bets and CFDs are leveraged products. Spread Betting and CFD trading typically require the deposit of a small percentage of the total trade value, profits & losses can quickly exceed your deposits requiring you to make further payments. Ensure that you understand the risks as these products are not suitable for everyone, if you are in doubt seek personal advice. This website does not constitute investment advice.

You can find details of the charges for particular Markets within the relevant Market Information tab, which is located on the Trading Platform next to each Market or by calling IG on 0207 573 0055. Hargreaves Lansdown Asset Management is authorised and regulated by the Financial Conduct Authority, FCA Register number 115248. IG is a trading name of IG Markets Limited and IG Index Limited. CFDs provided by IG Markets Limited, spread betting provided by IG Index Limited. Both IG Markets Limited (register number 195355) and IG Index Limited (register number 114059) are authorised and regulated by the Financial Conduct Authority.

Please ensure you have read the CFD Key Information Document and Spread Betting Key Information Document to better understand the nature, risks and costs of CFD and Spread Betting products, as well as your potential gains and losses when using them before deciding to invest.

Statutory disclosures | What are the risks? | Privacy Policy | Site map | Accessibility